Lankford Wade was appointed Chief Financial Officer of U.S. Anesthesia Partners, Inc. in March, 2016. He joined USAP from Aetna, Inc., where he spent nearly five years in progressively increasing roles, most recently serving as Vice President, Chief Financial Officer of Aetna’s Institutional Businesses. In this role, Mr. Wade was an instrumental member of the executive team which supported Aetna local market commercial and Medicare products as well as Aetna National Accounts and Specialty businesses, representing in excess of $50 billion in annual revenue.

Prior to Aetna, Mr. Wade worked with HealthSpring, Inc., where he was Senior Vice President, Corporate Development and Treasurer of the NYSE listed Medicare HMO, serving more than one million members prior to its sale to CIGNA. In 2003, he joined General Atlantic, LLC, a late-stage private equity firm, where he focused on investments in the healthcare sector. Mr. Wade started his career with Morgan Stanley as an Analyst and Associate in the Technology Group where he completed 11 financing transactions raising more than $6.6 billion in capital.

Mr. Wade holds an A.B. degree, summa cum laude, in Economics from Princeton University and was elected Phi Beta Kappa.​